Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm NCT07012863

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting - - a Randomized Controlled Study

Sponsor: Vastra Gotaland Region

Conditions Aortic Rupture Bleeding Blunt Injury Gastrointestinal Hemorrhage Obstetric Bleeding Penetrating Injury

Interventions Dry plasma

Updated 2 times since 2025 Last updated: Sep 16, 2025 Started: Jan 1, 2026 Primary completion: Jun 30, 2027 Completion: Sep 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Aortic Rupture and Bleeding and is currently actively recruiting participants. Vastra Gotaland Region leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Not Yet Recruiting PHASE4
Jul 2025 — Oct 2025 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vastra Gotaland Region

Data source: Vastra Gotaland Region

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.